GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » FCF Margin %

GlaxoSmithKline Pharmaceuticals (BOM:500660) FCF Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GlaxoSmithKline Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. GlaxoSmithKline Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was ₹9,179 Mil. Therefore, GlaxoSmithKline Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, GlaxoSmithKline Pharmaceuticals's current FCF Yield % is 1.31%.

The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's FCF Margin % or its related term are showing as below:

BOM:500660' s FCF Margin % Range Over the Past 10 Years
Min: -3.48   Med: 10.38   Max: 23.78
Current: 16


During the past 13 years, the highest FCF Margin % of GlaxoSmithKline Pharmaceuticals was 23.78%. The lowest was -3.48%. And the median was 10.38%.

BOM:500660's FCF Margin % is ranked better than
85.34% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs BOM:500660: 16.00


GlaxoSmithKline Pharmaceuticals FCF Margin % Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals FCF Margin % Chart

GlaxoSmithKline Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.38 18.41 23.78 13.64 16.00

GlaxoSmithKline Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's FCF Margin % falls into.



GlaxoSmithKline Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GlaxoSmithKline Pharmaceuticals's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=5507.94/34417.708
=16.00 %

GlaxoSmithKline Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=0/9178.608
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GlaxoSmithKline Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines